- Home
- JANX vs HI Comparison
JANX vs HI Comparison
Compare JANX & HI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- HI
- Stock Information
- Founded
- JANX 2017
- HI 2007
- Country
- JANX United States
- HI United States
- Employees
- JANX N/A
- HI N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- HI Miscellaneous manufacturing industries
- Sector
- JANX Health Care
- HI Consumer Discretionary
- Exchange
- JANX Nasdaq
- HI Nasdaq
- Market Cap
- JANX 1.5B
- HI 1.6B
- IPO Year
- JANX 2021
- HI N/A
- Fundamental
- Price
- JANX $25.96
- HI $22.13
- Analyst Decision
- JANX Strong Buy
- HI Hold
- Analyst Count
- JANX 8
- HI 2
- Target Price
- JANX $90.63
- HI $24.00
- AVG Volume (30 Days)
- JANX 839.1K
- HI 477.0K
- Earning Date
- JANX 08-06-2025
- HI 08-06-2025
- Dividend Yield
- JANX N/A
- HI 4.07%
- EPS Growth
- JANX N/A
- HI N/A
- EPS
- JANX N/A
- HI N/A
- Revenue
- JANX $9,336,000.00
- HI $3,047,000,000.00
- Revenue This Year
- JANX N/A
- HI N/A
- Revenue Next Year
- JANX $1,470.82
- HI N/A
- P/E Ratio
- JANX N/A
- HI N/A
- Revenue Growth
- JANX 28.12
- HI 0.30
- 52 Week Low
- JANX $22.48
- HI $18.36
- 52 Week High
- JANX $71.71
- HI $45.33
- Technical
- Relative Strength Index (RSI)
- JANX 53.36
- HI 54.37
- Support Level
- JANX $25.81
- HI $21.12
- Resistance Level
- JANX $27.31
- HI $22.58
- Average True Range (ATR)
- JANX 1.30
- HI 0.84
- MACD
- JANX 0.08
- HI -0.03
- Stochastic Oscillator
- JANX 45.02
- HI 50.84
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About HI Hillenbrand Inc
Hillenbrand Inc is a industrial company that provides engineered processing equipment and solutions to customers around the world. The company operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment and also provider of engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.